Atrophy, metabolism and cognition in the posterior cortical atrophy spectrum based on Alzheimer's disease cerebrospinal fluid biomarkers

INTRODUCTION: In vivo clinical, anatomical and metabolic differences between posterior cortical atrophy (PCA) patients presenting with different Alzheimer's disease (AD) cerebrospinal fluid (CSF) biomarkers profiles are still unknown. METHODS: Twenty-seven PCA patients underwent CSF examination...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuroimage Clin
Auteurs principaux: Montembeault, Maxime, Brambati, Simona M., Lamari, Foudil, Michon, Agnès, Samri, Dalila, Epelbaum, Stéphane, Lacomblez, Lucette, Lehéricy, Stéphane, Habert, Marie-Odile, Dubois, Bruno, Kas, Aurélie, Migliaccio, Raffaella
Format: Artigo
Langue:Inglês
Publié: Elsevier 2018
Sujets:
Regular Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6197495/
https://ncbi.nlm.nih.gov/pubmed/30340200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nicl.2018.10.010
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires